Tokyo, (JCN) - Takeda Pharmaceutical announced on March 2 that the US District Court in Chicago dismissed a legal action launched by Abbott Laboratories against Takeda Pharmaceutical in 2005.

Abbott claimed that Takeda Pharmaceutical had unjustly earned profits from its supply of lansoprazole to TAP Pharmaceutical Product, a joint venture company between Abbott and Takeda. Further, Abbott alleged that Takeda would have to pay a portion of its profits to Abbott.

The US District Court, however, ruled on February 24 that Abbott must file a lawsuit in Japan in line with its existing agreement with Takeda and TAP; accordingly the Court dismissed the action by Abbott.

By Aki Tsukioka, JCN Staff Writer

Company Profile

Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK